JPMorgan Chase & Co. Grows Stock Position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

JPMorgan Chase & Co. increased its position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 266.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 85,714 shares of the company’s stock after purchasing an additional 62,319 shares during the quarter. JPMorgan Chase & Co.’s holdings in Aveanna Healthcare were worth $446,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in AVAH. Creative Planning grew its holdings in shares of Aveanna Healthcare by 21.3% during the third quarter. Creative Planning now owns 48,502 shares of the company’s stock worth $252,000 after buying an additional 8,502 shares in the last quarter. State Street Corp boosted its position in Aveanna Healthcare by 0.9% during the third quarter. State Street Corp now owns 1,039,920 shares of the company’s stock worth $5,408,000 after acquiring an additional 9,446 shares during the last quarter. Mackenzie Financial Corp grew its stake in Aveanna Healthcare by 35.9% during the 2nd quarter. Mackenzie Financial Corp now owns 45,674 shares of the company’s stock valued at $126,000 after acquiring an additional 12,075 shares in the last quarter. Intech Investment Management LLC purchased a new position in Aveanna Healthcare in the 3rd quarter worth approximately $69,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Aveanna Healthcare by 3.9% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 462,659 shares of the company’s stock worth $2,406,000 after purchasing an additional 17,522 shares during the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Truist Financial cut their price target on Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating for the company in a report on Monday, January 6th.

Aveanna Healthcare Stock Performance

AVAH stock opened at $4.81 on Wednesday. Aveanna Healthcare Holdings Inc. has a one year low of $2.00 and a one year high of $6.19. The firm has a market cap of $929.44 million, a PE ratio of -14.15 and a beta of 2.25. The firm’s 50 day moving average price is $4.96 and its 200-day moving average price is $4.95.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.03. The company had revenue of $509.02 million for the quarter, compared to analysts’ expectations of $495.80 million. During the same period last year, the business earned ($0.05) EPS. Equities research analysts predict that Aveanna Healthcare Holdings Inc. will post -0.07 EPS for the current fiscal year.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.